Healthcare Asia Summit - March 25, 2026

Alex Boulton is a member of our Private Equity and Healthcare & Life Sciences practices.

He leads our Healthcare and Life Sciences practice for Southeast Asia and, since joining Bain in 2010, Alex has led numerous strategy and transformation programs with healthcare companies across the region and value chain; covering payers, providers, pharma, MedTech and digital health. In addition, he leads the Healthcare sector for our APAC private equity practice, supporting healthcare commercial due-diligence, portfolio and fund strategy engagements.

He holds a BSc in Economics, with First-Class Honours, from the London School of Economics and Political Science.

Dr Melvyn Chin is the Associate Director (PSM) for ECRI Asia Pacific and is responsible for creating products, solutions and research initiatives related to patient safety and healthcare as well as supporting business development and project management in the APAC region. Prior to joining ECRI, Dr Melvyn was the National Technical Advisor for Occupational Safety and Health for all public hospitals and medical institutions in Malaysia, a committee board member for the Medical Research Ethics Committee MOH Malaysia, the Head of the Occupational Safety and Health Unit and the Deputy Head of Clinical Research Centre for a tertiary hospital in Malaysia. 

Dr Melvyn is an experienced occupational health clinician and health research bioethicist with a demonstrated history of working in the medical practice industry and healthcare management.

Dr Melvyn graduated with an MBBS medical degree from Melaka Manipal Medical College. He received his Licentiate of the Faculty of Occupational Medicine from the Royal College of Physicians in 2015 and obtained Leadership in Medicine certification from Harvard Medical School in 2021. In 2023, he completed his Masters in Health Research Ethics with distinction from University Malaya in collaboration with the Berman Institute of Bioethics at Johns Hopkins University.
 

Uli is leading the technology, digital transformation and data agenda for Fullerton Health. In this role he spearheads the rollout of core IT and TPA systems across all Fullerton Health sites, drives adoption of AI and Automation to enhance operational excellence and establish a robust data management framework to enable data-driven decision-making. He is also leading the development of Customer-Centric digital platforms, empowering customers with seamless access to Fullertons’ healthcare ecosystem.

Uli has three decades of international experience, primarily in Asia and Europe. He has held senior leadership roles at major organizations such as Wipro, Atos and HP. His expertise spans cloud strategy, digital platforms, cybersecurity, data analytics, edge computing, and large-scale application development. He has a proven track record of leading transformation initiatives, building high-performance teams, and delivering complex, high-value projects for global clients across banking, government, and health sectors.
 

Professor Aymeric Lim is Chief Executive Officer of National University Hospital and Senior Consultant in its Department of Hand & Reconstructive Microsurgery. He is also Professor in the Department of Orthopaedic Surgery at the NUS Yong Loo Lin School of Medicine. With three decades of experience, he is internationally recognised for his work in peripheral nerve surgery and upper limb reconstruction. Under his leadership, NUH drives a digital-first strategy, pioneering AI in patient care to deliver smarter, faster, and more personalised outcomes. Professor Lim’s career spans leadership in healthcare, education, and humanitarian missions, earning him numerous national accolades for excellence and service.

Dr Eugene Shum is Director, Strategic Community Partnership at the SingHealth Office of Regional Health. He is also Senior Population & Public Health Consultant at Changi General Hospital. Through partnerships with community organisations, he has developed pioneering health-social initiatives such as the Neighbours for Active Living programme and CareLine, a 24/7 nationwide telecare service. These initiatives received the Ministry of Health National Clinical Excellence Team Awards in 2024 and 2022 respectively. Dr Shum has a special interest in urban health and the built environment where he has led initiatives such as the Pelatok Art Farm. He was previously Chief Corporate Development Officer at Eastern Health Alliance and Director, Medical Affairs and Innovation at Khoo Teck Puat Hospital. He has held various portfolios at the Ministry of Health, Singapore.

Dr Shum is a public health physician. He obtained his MBBS from the National University of Singapore and his Master of Public Health from the Bloomberg School of Public Health, Johns Hopkins University. He is Adjunct Associate Professor at the Saw Swee Hock School of Public Health, National University of Singapore and the Singapore University of Technology and Design. He was awarded the Public Service Medal (Pingat Bakti Masyarakat) in 2020.

Anastasia is passionate about partnering for outcomes, innovating for impact and leveraging digital and data to deliver value for people across the healthcare ecosystem.

Anastasia has over 20 years global and regional Life Sciences (MedTech, Pharma and Digital Health) and Healthcare (Public and Private) industry experience delivering large-scale transformation initiatives across a variety of first-line and second-line roles. Anastasia couples her strategic and sector expertise with strong data science and engineering foundations and qualifications to help drive, create and translate value across the healthcare ecosystem; for patients, providers, businesses and systems. Anastasia key focus areas are on developing and executing on pragmatic strategies related to (1) digital, data and AI  (2) commercial models and new product development and (3) innovation and emerging technology

Clinical Associate Professor Tan Hiang Khoon is a dynamic clinician leader who is currently serving as the CEO Singapore General Hospital. His career trajectory includes several key leadership roles within SingHealth. From 2021 to 2024, he served concurrently as Group Director of the International Collaboration Office (ICO) at SingHealth and Director of the SingHealth Duke-NUS Global Health Institute (SDGHI). Additionally, he took on the role of Deputy CEO (Future Health System), SGH from 2022 to 2024. Prior to these appointments, Dr Tan was the Chair of Surgery from 2015 to 2022.

With a distinguished career in head and neck surgery and surgical oncology, Dr Tan has made significant strides in healthcare leadership. He spearheaded the creation of the SingHealth Duke-NUS Head and Neck Disease Centre in 2013. As Chair of surgery, he led the integration of the Division of Surgery at Singapore General Hospital with the Division of Surgical Oncology at the National Cancer Centre Singapore to optimise care of surgical patients. Notably, during the COVID-19 pandemic, he established a 3,700-bed Community Care Facility, ensuring hospital capacities were maintained.

Dr Tan is dedicated to global health equity; he founded the Global Surgery Programme and initiated the Asian Surgical Leaders Network, which addresses the pandemic's impact on surgical health systems in Asia and develops strategies for health system resilience. His commitment to cost-conscious innovation led to a partnership with Duke University, resulting in a low-cost portable flexible nasopharyngoscope, enhancing diagnostic access in lower-resourced settings.

Dr Tan holds a medical degree from the National University of Singapore, a Ph.D. from the University of Bristol, and advanced training in head and neck surgical oncology from the Institute Gustave Roussy in Paris. He also earned an Executive Master in Business Administration from the National University of Singapore.

Jonathan is a Senior Associate in Baker McKenzie Wong & Leow's IPTech practice. Jonathan works closely with a range of clients in the healthcare industry, ranging from multinational pharmaceutical and medical device companies, biotech and medtech start-ups, to healthcare service providers. He advises keenly on healthcare regulatory issues, including market entry, compliance, commercial and contentious matters. He also advises on emerging trends in the healthcare industry, such as AI in healthcare and digital health issues.

Beaver R. Tamesis, MD has been the President and Chief Executive Officer of Asian Hospital and Medical Center since November 1, 2022. Asian Hospital is part of Metro Pacific Health, the largest ne work of private hospitals in the Philippines.

A cardiologist by profession, Dr. Tamesis has been board-certified by the Philippine Heart Association since 1991. He is internationally published in cardiology and structured treatment protocols for diabetes, and continues to actively practice at The Medical City, where he previously served as Training Officer for Internal Medicine and later founded the Cardiology Fellowship Training Program. He is a Fellow in good standing of both the Philippine College of Physicians and the Philippine College of Cardiology.

Before joining Asian Hospital, Dr. Tamesis served as Managing Director and President of Merck Sharp and Dohme (MSD) I.A. LLC, a leading multinational pharmaceutical company. Over his 27-year career with MSD, he held key roles including Medical Director, Business Unit Director for Bone and Joint and Cardio-Metabolic, and Regional Marketing Director for the launch of the diabetes drug JANUVIA. He led MSD Philippines from 2013 until his retirement in March 2022.

While at MSD, he also served as President of the Pharmaceutical and Healthcare Association of the Philippines (PHAP) from 2016 to 2021, following two years as Trustee. In this role, he championed et ical business practices, worked closely with the Department of Health and the media to combat medical disinformation—particularly around vaccines and COVID-19—and helped shape a rational approach to medicine pricing in the country.

Under his leadership, Asian Hospital and Medical Center has achieved sustained excellence and recognition both locally and internationally. The hospital was reaccredited by the Joint Commission International (JCI) in 2025, reaffirming its commitment to world-class quality and patient safety. It has also been a three-time Gold Award winner at the Hospital Management Asia (HMA) Awards for Clinical Effectiveness and Financial Improvement (2023–2025). In 2024, Dr. Tamesis received the HMA Excellence Award as Hospital CEO of the Year, recognizing his transformative leadership and organizational innovation.

Beyond HMA, Asian Hospital has been honored by the Healthcare Asia Awards for excellence in clinical service, patient care, management innovation, and workforce transformation; by the World Stroke Organization (WSO) Angels Awards for acute stroke care; and by the Anvil Awards with multiple Gold and Silver recognitions for outstanding communications and public relations programs. The hospital has also been named among the Philippines’ Best Employers by the Philippine Daily Inquirer.

In 2025, Dr. Tamesis was named CEO of the Year at the Philippines Leadership Awards and Philippines Executive of the Year (Healthcare) at the Asian Management Excellence Awards. He was also included in the Asia CEO Awards’ Circle of Excellence as CEO of the Year—a testament to his vision, integrity, and unwavering commitment to advancing healthcare excellence in the Philippines.
 

Adj Prof Tang Kong Choong leads Tan Tock Seng Hospital (TTSH) with a clear vision to advance tertiary care and academic excellence, underpinned by digital transformation and workforce renewal. As Chief Executive Officer (CEO), he drives Phase 2 of the HealthCity Novena Masterplan, elevating TTSH’s role as a future-ready hub of care and learning. An accredited anaesthetist, Prof Tang has held progressive leadership roles in TTSH since 2020, moving from Senior Consultant to Assistant CEO, then Deputy CEO. Prior to this, he had a distinguished career with the Singapore Armed Forces, where he served as Chief of Medical Corps. There, he led key innovations in medical support systems, electronic health records, and paramedic training. He also chaired the National Advanced Trauma Life Support Committee and served as board director of the Agri-Food and Veterinary Authority. Prof Tang’s career reflects his commitment to advancing both clinical and operational excellence in healthcare.